319 related articles for article (PubMed ID: 16545497)
1. Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors.
Mu L; Drandarov K; Bisson WH; Schibig A; Wirz C; Schubiger PA; Westera G
Eur J Med Chem; 2006 May; 41(5):640-50. PubMed ID: 16545497
[TBL] [Abstract][Full Text] [Related]
2. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
Huang Y; Zhu Z; Xiao Y; Laruelle M
Bioorg Med Chem Lett; 2005 Oct; 15(19):4385-8. PubMed ID: 16039849
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.
Dallanoce C; Matera C; Pucci L; Gotti C; Clementi F; Amici MD; Micheli CD
Bioorg Med Chem Lett; 2012 Jan; 22(2):829-32. PubMed ID: 22222032
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
Wei ZL; Xiao Y; Kellar KJ; Kozikowski AP
Bioorg Med Chem Lett; 2004 Apr; 14(8):1855-8. PubMed ID: 15050615
[TBL] [Abstract][Full Text] [Related]
5. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
Gao Y; Horti AG; Kuwabara H; Ravert HT; Hilton J; Holt DP; Kumar A; Alexander M; Endres CJ; Wong DF; Dannals RF
J Med Chem; 2007 Aug; 50(16):3814-24. PubMed ID: 17629263
[TBL] [Abstract][Full Text] [Related]
6. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of N-[11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors.
Horti AG; Scheffel U; Kimes AS; Musachio JL; Ravert HT; Mathews WB; Zhan Y; Finley PA; London ED; Dannals RF
J Med Chem; 1998 Oct; 41(22):4199-206. PubMed ID: 9784094
[TBL] [Abstract][Full Text] [Related]
8. Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
Bisson WH; Scapozza L; Westera G; Mu L; Schubiger PA
J Med Chem; 2005 Aug; 48(16):5123-30. PubMed ID: 16078832
[TBL] [Abstract][Full Text] [Related]
9. Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
Wei ZL; Xiao Y; Yuan H; Baydyuk M; Petukhov PA; Musachio JL; Kellar KJ; Kozikowski AP
J Med Chem; 2005 Mar; 48(6):1721-4. PubMed ID: 15771418
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and radiosynthesis of [(18)F]FPhEP, a novel alpha(4)beta(2)-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors.
Roger G; Saba W; Valette H; Hinnen F; Coulon C; Ottaviani M; Bottlaender M; Dollé F
Bioorg Med Chem; 2006 Jun; 14(11):3848-58. PubMed ID: 16455259
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
Carroll FI; Ma W; Yokota Y; Lee JR; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
J Med Chem; 2005 Feb; 48(4):1221-8. PubMed ID: 15715488
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
Carroll FI; Lee JR; Navarro HA; Ma W; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2002 Oct; 45(21):4755-61. PubMed ID: 12361403
[TBL] [Abstract][Full Text] [Related]
14. Neuronal nAChR stereoselectivity to non-natural epibatidine derivatives.
Bertrand S; Patt JT; Spang JE; Westera G; Schubiger PA; Bertrand D
FEBS Lett; 1999 May; 450(3):273-9. PubMed ID: 10359088
[TBL] [Abstract][Full Text] [Related]
15. 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.
Koren AO; Horti AG; Mukhin AG; Gündisch D; Kimes AS; Dannals RF; London ED
J Med Chem; 1998 Sep; 41(19):3690-8. PubMed ID: 9733494
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands.
Bhatti BS; Strachan JP; Breining SR; Miller CH; Tahiri P; Crooks PA; Deo N; Day CS; Caldwell WS
J Org Chem; 2008 May; 73(9):3497-507. PubMed ID: 18363376
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs.
Ondachi PW; Ye Z; Castro AH; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
Bioorg Med Chem; 2015 Sep; 23(17):5693-701. PubMed ID: 26233800
[TBL] [Abstract][Full Text] [Related]
18. Epibatidine structure-activity relationships.
Carroll FI
Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine.
Carroll FI; Robinson TP; Brieaddy LE; Atkinson RN; Mascarella SW; Damaj MI; Martin BR; Navarro HA
J Med Chem; 2007 Dec; 50(25):6383-91. PubMed ID: 17994682
[TBL] [Abstract][Full Text] [Related]
20. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
